European Archives - Page 289 of 1659 - European Medical Journal

AI tools

AI Tools Can Improve Accuracy in Chest Radiograph Reporting

AI-prefilled structured reporting improves diagnostic accuracy in chest radiograph reporting compared with free-text reporting, a 2026 prospective reader study has found.

Hema Now: Advancing Care in Myelofibrosis

In this episode of Hema Now, we take a deep dive into myeloproliferative neoplasms (MPN), with a particular focus on myelofibrosis, one…

US state building

Rare disease care access uneven across the US

A new report has found that for Americans living with rare conditions, access to the latest innovations depends on their zip code.

Corrigendum: Acne Treatment Review and Present Perspectives

Mechanical thrombectomy

Mechanical Thrombectomy Improves Outcomes in Pulmonary Embolism

STORM-PE shows that mechanical thrombectomy leads to greater early improvement in right ventricular function than anticoagulation alone in intermediate-high risk pulmonary embolism, without increased major adverse events.

Alzheimer’s

Kidney Function Linked to Elevated Alzheimer’s Blood Biomarkers

A large meta-analysis links reduced kidney function to higher Alzheimer’s disease blood biomarkers, suggesting renal health may affect interpretation of dementia tests.

diabetic retinopathy

Gut Microbiota Dysbiosis is a Factor in Diabetic Retinopathy

Gut microbiota dysbiosis might contribute to the development of diabetic retinopathy through the gut-eye axis, according to a 2026 systematic review and meta-analysis.

Mediterranean diet

Mediterranean Diet Linked to Lower Stroke Risk in Women

Long-term data from California Teachers Study show higher adherence to the Mediterranean diet is linked to reduced risk of stroke in women.

Crohn’s disease

Fecal Metabolites Linked to Crohn’s Disease Progression

Fecal metabolites interact with gut microbes in Crohn’s disease, revealing signals that could guide new treatments and dietary strategies.

benign prostatic hyperplasia

Gut Microbiota Links to Benign Prostatic Hyperplasia

A systematic review reveals how gut microbiota changes, inflammation, and intestinal barrier dysfunction may influence benign prostatic hyperplasia development.